Bezafibrate

This classification denotes an anti-lipidemic agent with the molecular formula C19H20ClNO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y9449Q51XH, chemically known as propionic acid, 2-(4-(2-((4-chlorobenzoyl)amino)ethyl)phenoxy)-2-methyl- but generally known as bezafibrate, which bears US NIH Compound Identifier 39042. European Medicines Agency schedules Bezafibrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05810MIG. The term BEZAFIBRATE is an International Non-Proprietary Name. World Health Organization schedules bezafibrate in its Anatomical Therapeutic Chemical (ATC) Classification. BEZAFIBRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bezafibrate under HS 29242995 and SITC 51479. As of Q4 2014, BEZAFIBRATE remains the US FDA Preferred Term for this commodity. Bezafibrate bears US NLM identifiers UMLS ID C0005330 and NCI Concept Code C87449. SMILES: Clc1ccc(C(=O)NCCc2ccc(OC(C)(C)C(=O)O)cc2)cc1.